This group conducts phase I, II and III sarcoma clinical trials with an emphasis on translational studies and immunotherapy.
Professor Robin Jones is Group Leader in Sarcoma Clinical Trials at The Institute of Cancer Research and Consultant Medical Oncologist at The Royal Marsden. He is a specialist in the treatment of bone and soft tissue sarcomas, and focuses on developing novel therapies for these diseases.